Abstract In contrast to extracellular plaque and intracellular tangle pathology, the presence and relevance of intraneuronal Ab in Alzheimer's disease (AD) is still a matter of debate. Human brain tissue offers technical challenges such as post-mortem delay and uneven or prolonged tissue fixation that might affect immunohistochemical staining. In addition, previous studies on intracellular Ab accumulation in human brain often used antibodies targeting the C-terminus of Ab and differed strongly in the pretreatments used. To overcome these inconsistencies, we performed extensive parametrical testing using a highly specific N-terminal Ab antibody detecting the aspartate at position 1, before developing an optimal staining protocol for intraneuronal Ab detection in paraffin-embedded sections from AD patients. To rule out that this antibody also detects the b-cleaved APP C-terminal fragment (b-CTF, C99) bearing the same epitope, paraffin-sections of transgenic mice overexpressing the C99-fragment were stained without any evidence for cross-reactivity in our staining protocol. The staining intensity of intraneuronal Ab in cortex and hippocampal tissue of 10 controls and 20 sporadic AD cases was then correlated to patient data including sex, Braak stage, plaque load, and apolipoprotein E (ApoE) genotype. In particular, the presence of one or two ApoE4 alleles strongly correlated with an increased accumulation of intraneuronal Ab peptides. Given that ApoE4 is a major genetic risk factor for AD and is involved in neuronal cholesterol transport, it is tempting to speculate that perturbed intracellular trafficking is involved in the increased intraneuronal Ab aggregation in AD.
Introduction
Genetic studies on familial Alzheimer's disease (AD) patients have revealed mutations in genes linked to the beta amyloid (Ab) generating cascade. Although this provides strong support for the amyloid hypothesis as the underlying pathological mechanism of AD [30] , some controversies remain to be resolved. For instance, the accumulation of extracellular Ab plaques does not correlate with the cognitive decline observed in AD patients [1] . In addition, a massive loss of neurons around plaques is not seen in human brain [54] and only rarely observed after the onset of Ab plaque pathology in various different mouse models [22, 24] .
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One possible explanation is that, rather than extracellular Ab plaque deposition, accumulation of Ab inside neurons could be driving AD pathology, and may eventually lead to intracellular deficits in function and neuronal loss [25, 37, 68] . Intraneuronal Ab has been reported to disrupt fast axonal transport (FAT) in isolated axoplasms [50] , to impair multi vesicular body (MVB) sorting by inhibition of the ubiquitin-proteasome system [2] and to induce synaptic dysfunction leading to reduced PSD-95 and consequently GluR1 levels in synapses [3] .
The accumulation of intraneuronal Ab peptides in AD brain has been sporadically reported since the late 1980s [27] . However, initial problems with the inability of the antibodies to separate between full length amyloid precursor protein (APP) and Ab itself founded a skepticism toward the presence of intraneuronal Ab that has been difficult to eliminate [25, 37] . Despite the initial technical complications, several studies using Ab40/42 end-specific antibodies have later reported the presence of intraneuronal Ab in AD and healthy controls [17-19, 23, 26, 44, 46, 65] , as well as in Down syndrome patients who are known to develop AD at an early age [29, 45] . One study isolated human hippocampal pyramidal neurons from the CA1 of AD patients by laser capture microdissection, determined Ab peptide levels using ELISA quantification and reported an increased intraneuronal Ab42/Ab40 ratio in AD patients compared to controls [4] . Still, the presence and impact of intraneuronal Ab in human AD tissue is a matter of controversial debate [22] .
The data on intraneuronal Ab in AD mouse models are quite consistent; intraneuronal Ab was first reported in familial PS1 transgenic mice that also showed neurodegeneration but no plaques [15] . During the last years, it has been convincingly reported in several mouse models including APP SDL PS1 M146L [69] , APP SL PS1 M146L [70] , Tg2576 [60] , 3xTg-AD [48] , 5xFAD [47] , APP Arc [33, 40] , APP T714I mice [63] , and in APP SL PS1KI M233T,L235P mice [10] in which it was recently shown to correlate with neuron loss [8, 12, 14] , as well as in a recently described mouse model expressing only pyroglutamate modified Ab peptides within neurons [67] .
Compared to mouse tissue, human tissue is more variable and factors like post-mortem delay, agonal state, and uneven tissue fixation, often of a prolonged duration, can interfere with immunohistochemical results. Although pHdependent heat pretreatment is commonly used to reliably retrieve masked antigens from formalin-fixed, paraffinembedded postmortem brain [41, 42, 58] , most of the staining protocols for intracellular Ab applied so far show considerable variation in use, duration and concentration of heat and formic acid (FA) treatment. Microwave heat pretreatment enhances the immunoreactive signal of intraneuronal Ab as compared to conditions in which no or enzymatic pretreatment was applied [18] . FA is widely used to increase the staining of plaque pathology in AD; yet, the effect of FA on intraneuronal Ab staining has been reported to be low and similar to the effect of heat [20] , or even to counteract the enhancing effect of heat pretreatment on intraneuronal Ab immunohistochemical detection [49] . On the other hand, formic acid pretreatment has been successfully used to improve aggregated a-synuclein staining in Lewy bodies and dystrophic neurites [61] .
The present study optimized the staining protocol for intraneuronal Ab using a highly specific N-terminal Ab antibody on human AD tissue after testing various pretreatment conditions of heat and/or FA. The optimized protocol was then used to screen a series of sporadic AD cases and non-demented controls for the intensity of intraneuronal Ab staining, which was then analyzed in a correlation analysis with patient data including ApoE genotype. A significant correlation between intraneuronal Ab accumulation and the presence of at least one ApoE4 allele was established.
Materials and methods

AD brain tissue
Paraffin-embedded blocks from cortex and hippocampus of AD (n = 20) and control patients (n = 10) were acquired from the Netherlands Brain Bank (NBB, Amsterdam, The Netherlands) [51] that works with a rapid autopsy program and aims to keep postmortem delay (PMD) to a minimum. The NBB abides to all local ethical legislation, and permission was obtained for all brain autopsies and for the use of the tissues and clinical data for research purposes. To minimize variation as much as possible, control subjects were matched to the AD cases for age, sex, fixation time, pH of the cerebrospinal fluid, and PMD. Tissue of all subjects was investigated by a team of trained neuropathologists using a range of conventional and neuropathological stainings. The presence or absence of neuropathological changes was confirmed in the hippocampus and a range of other brain regions including the frontal and temporal cortex and the cerebellum. None of the control subjects had suffered from any primary neurological or psychiatric disease or brain metastases nor did they have a history of drug treatment or medication.
At autopsy, the hippocampus was dissected and fixed in 0.1 mol/L phosphate-buffered 4% formaldehyde (Sigma, St. Louis, MO, USA) solution (pH 7.2) for a period of approximately 4-5 weeks. Tissue was then dehydrated in graded ethanol and embedded in paraffin. 4-lm-thick tissue sections were cut for all patients from the midlevel of the hippocampus on a Leica microtome and mounted on SuperFrost Plus slides (Menzel-Gläser, Braunschweig, Germany). The following data were available for each patient: diagnosis, gender, age, post-mortem delay, disease duration, pH CSF, Braak stage, ApoE genotype, brain weight, as well as the medical history. In addition, information on extracellular plaque load was provided which contains a semi-quantitative score based on silver and 6F/3D (DAKO, Denmark, 1:400) immunostainings ranging from O (very few) to C (heavy plaque load) ( Table 1) .
The APOE genotyping of all patients was done according to standard protocols [66] . In brief, frozen human cortical samples were physically homogenized and powdered. DNA was then extracted and purified using standard methodology. Subsequently, parts of the APOE gene were amplified by means of PCR before the amplified DNA was fragmented using the restriction enzyme CfoI that is single nucleotide polymorphism (SNP) sensitive. Fragment size was then evaluated from their mobility in PolyNat gel system stained with SYBR-Green [31] .
Immunohistochemistry on formalin-fixed, paraffin-embedded sections Immunohistochemistry was performed as described previously [70] . In brief, sections were deparaffinized in xylene and rehydrated in a series of ethanol. After treatment with 0.3% H 2 O 2 in PBS to block endogenous peroxidases, either no further treatment was applied or antigen retrieval was performed by boiling sections for 10 min in a microwave oven in 0.01 M citrate buffer pH 6.0 and/or incubating sections for 3 min in 88% FA. After long-term fixation, various antigens can be masked by formalin crosslinks Fig. 1 ). Intraneuronal Ab intensity was rated in the hippocampal region based on Ab[N] staining intensity in CA4, CA3, and CA1 corresponding to either: no staining in any of the regions: 0 (-); weak staining in CA4 and CA3, but nothing in CA1: 1 (?); moderate staining in CA4 and CA3, but nothing or little in CA1: 2 (??); intense staining in all three regions: 3 (???) (Fig. 4a-l) .
Double immunocytochemical staining was visualized using the ABC method with DAB together with the HistoGreen kit (Linaris, Germany) providing a blue color. Counterstaining was carried out with hematoxylin.
Statistical analysis
Kolmogorov-Smirnov test was applied to examine which variables showed significant deviations from normal distribution. Most of the parameters, especially intraneuronal Ab, showed significant deviation from normal distribution, and thus non-parametric tests were performed in the following analyses. Spearman rank correlations were calculated between intraneuronal Ab and age, brain weight, extracellular plaque load, and post-mortem delay. Nonparametric Mann-Whitney U test was performed between intraneuronal Ab and the factors gender, diagnosis, and number of ApoE 4 alleles. Non-parametric Kruskal-Wallis tests were computed between intraneuronal Ab and Braak stage, where subgroup analysis between two groups was performed with Mann-Whitney U tests. As the study is explorative, the P values are given without Bonferroni adjustments. A binary logistic regression with dependent variable number of ApoE 4 alleles (0, C1) and independent variables intraneuronal Ab, diagnosis, gender, age, and Braak stage was computed with the enter method, including all specified independent variables in the model. That way, the analysis on a correlation between intraneuronal Aß and ApoE 4 alleles was controlled for the indicated variables.
Results
Effect of formic acid and heat on staining of intraneuronal Ab in AD patients
Optimization for intraneuronal Ab staining was performed in hippocampal paraffin sections of sporadic AD cases using the Ab N-terminal antibody detecting Ab peptides starting with an aspartate at position 1. This antibody has been previously reported not to cross-react with full-length APP or b-C-terminal fragments [13, 35] . In addition, no cross-reactivity to APP C-terminal fragments could be demonstrated by staining SPA4CT mice overexpressing the b-cleaved APP C-terminal fragment C99. While strong immunoreactivity using a C-terminal APP antibody could be demonstrated in dentate gyrus granule cells and axonal fiber tracts like the corpus callosum, staining with the Ab[N] antibody was consistently negative ( Supplementary  Fig. 1 ). Even without any antigen retrieval, a faint fairly homogenous intraneuronal Ab 1-x staining could be detected (Fig. 1a) . Yet, 10-min heat treatment in 0.01 M citric acid buffer pH 6 dramatically increased the intraneuronal Ab 1-x staining showing a granular staining pattern and concentration around the nucleus (Fig. 1b) . Compared to no pretreatment, 3-min FA pretreatment did not improve the staining of intracellular Ab 1-x (Fig. 1c) , and actually very clearly counteracted the enhancing effect of the heat pretreatment on intraneuronal Ab 1-x staining (Fig. 1d) . In addition to the fairly homogenous and punctate staining in the cytoplasm, some nuclei were observed to be surrounded by a highly granular Ab staining pattern and were present in all three AD cases, and with all applied protocols (Fig. 1c) . Double labeling for Ab 1-x and astrocytes using the Ab[N] antibody visualized by DAB and the GFAP antibody visualized by Histogreen revealed that this highly abundant granular staining pattern in CA4 and CA3 of the hippocampal formation of many sporadic AD cases to be astrocytes accumulating Ab (Fig. 2a, b, black arrows) . In a few cases, astrocytes with no granular Ab accumulation could be found in close proximity to neurons (Fig. 2c, d) .
The presence of intraneuronal Ab in the hippocampal region of sporadic AD cases was confirmed qualitatively by staining using the OC antibody recognizing Ab fibrils and fibrillar oligomers [32] . The OC antibody produced an intraneuronal staining much like that of Ab[N] with heat pretreatment alone (Fig. 3a, b ) as well as with combined heat and 3-min FA pretreatment. The latter was actually slightly more intense than that enhanced by heat alone (Fig. 3c, d) .
The widely used 4G8 antibody was applied to further confirm the presence of intraneuronal Ab using heat pretreatment and was found to produce a prominent and intense granular staining. This pattern differed from that detected by OC or Ab[N] antibodies (Fig. 3e, f) , with the granules being much larger and surrounding the nucleus in a cap-like manner.
Intraneuronal Ab staining in sporadic AD and control patients
Hippocampal sections from 10 controls and 20 sporadic AD patients were stained with the Ab[N] antibody, and their intraneuronal Ab 1-x intensity was analyzed based on evaluation of the staining intensity in CA4, CA3, and CA1 ( Fig. 4a-l) . Four AD patients and two controls were found to accumulate the highest degree of intraneuronal Ab 1-x peptides, whereas nine AD patients and two controls accumulated a moderate amount of these Ab peptides. Six AD patients and four controls accumulated low amount of Ab peptides, whereas only one AD and two control patients were devoid of accumulation of Ab 1-x peptides (Table 1) . By non-parametric statistical analysis, the accumulation of intraneuronal Ab 1-x was found to show no correlation with age, brain weight, post-mortem delay, gender, diagnosis, or Braak stage; however, a correlation between intraneuronal Ab 1-x accumulation and extracellular plaque load was established (P = 0.0138, r = 0.4446). Surprisingly, the ApoE genotype was found to strongly correlate with the presence of intraneuronal Ab, where having one ApoE4 allele strongly correlated with increased intraneuronal Ab 1-x staining ( Table 2 ; P = 0.002), which was also significant after Bonferroni adjustment (P = 0.023). Furthermore, from binary logistic regression with dependent variable ApoE 4 alleles and independent variables intraneuronal Ab, diagnosis, gender, age, and Braak stage, there was only a significant influence of ApoE 4 alleles on intraneuronal Ab (Wald statistic = 5.85; P = 0.016; oddsratio = 16.38; 95% confidence interval = [1.70; 157.9]), while there was no significant influence of the other independent variables that the analysis was adjusted for. The rate of correct classifications for ApoE 4 alleles increased from 62 to 79% after the independent variables were entered to the model. To confirm the results of the Ab[N] staining in the detection of intraneuronal Ab peptides in human postmortem tissue, the same cohort of patients was stained using the commercially available antibody G2-10, which recognizes a neo-epitope at the C-terminus of Ab40 peptides ( Supplementary Fig. 2) . A correlation analysis between the staining pattern of the two antibodies revealed a highly significant correlation (P = 0.002; r = 0.55), corroborating the validity of the staining protocol.
Discussion
The effect of heat and FA pretreatment was semi-quantitatively investigated in human AD tissue using a highly specific N-terminal-specific antibody detecting Ab 1-x . It has been previously reported that this antibody specifically recognizes Ab peptides, without cross-reaction to APP or APP C-terminal fragments [13, 35] . The optimization was performed in paraffin-embedded hippocampal sections from sporadic AD cases by means of combinations of acid and heat pretreatments, essential conditions for antigen retrieval from brain tissue fixed for prolonged periods of time [42, 57, 62] . As the Ab[N] antibody is directed against the aspartate at position 1 of Ab, it might also detect APP C-terminal fragments bearing the same epitope. To overcome this problem, we stained tissue sections from a transgenic mouse model overexpressing the b-cleaved APP C-terminal fragment C99 (SPA4CT mice) [52] , and found no evidence for any cross-reactivity to b-CTF in formalin-fixed and paraffin-embedded material. However, residual cross-reactivity using other techniques cannot be completely ruled out. Some intraneuronal Ab 1-x staining was evident even without any pretreatment, but heat dramatically increased the intraneuronal staining of smaller granules throughout the cytoplasm concentrating around the nucleus in all investigated hippocampal regions, especially in the CA4 region. In contrast, FA pretreatment did not increase the staining of intraneuronal Ab 1-x as compared to sections Fig. 2 Double labeling of Ab 1-x in reddish brown (DAB) using Ab[N] antibody and astrocytes in blue (Histogreen, black arrowheads) using a GFAP antibody in paraffinembedded sections. The highly granular staining pattern surrounding the smaller nuclei was due to astrocytes accumulating Ab and was found in CA4 (a) as well as in CA3 (b) of many sporadic AD cases. However, in some AD cases, astrocytes without granular staining were found close to neurons in both CA4 (c) and CA3 (d). Scale bar 33 lm where no antigen retrieval was applied. In fact, FA even reduced the enhancing effect of heat; the combination of heat and FA only slightly increased the staining of Ab 1-x as compared to no pretreatment (Fig. 1d, h, l) , resulting in much less retrieval than heat alone. The counteracting effect of FA on the heat-induced staining of intraneuronal Ab 1-x peptides corroborates findings of another study using an Ab42(43) specific antibody (BC-05) and an autoclave heating protocol that reported a counteracting effect of FA on heat-induced Ab42 staining [49] and is in line with previous studies showing that FA preferentially retrieves nuclear rather than cytoplasmic antigens [7, 57, 62] . Taken together, the strong improvement in intraneuronal Ab immunoreactive signal after this pretreatment (c, d) . With 10-min heat pretreatment, the 4G8 antibody produced a different, highly abundant and granular intracellular staining (e, f). Bottom left corners of a, c, and e show intracellular staining at a high magnification. Scale bar 50 lm may explain discrepancies with older literature, where antigen retrieval was generally not applied.
These findings are in contrast to the observations in mouse models, where FA clearly enhanced staining of intraneuronal Ab peptides with heat yielding no, or only a minor increase [13] . The difference in the effect of heat and FA between mouse and human tissue could be explained by differences in the Ab species that accumulate in the cells. In the AD mouse models, much of the intraneuronal Ab induced by FA pretreatment seemed to be aggregated peptides. Possibly, the intraneuronal Ab 1-x in AD tissue could reflect soluble oligomeric species that may be enhanced by heat but counteracted by FA pretreatment. In agreement, low-n oligomeric Ab have been detected inside primary human neurons [64] .
The presence of intraneuronal Ab in sporadic AD tissue was further supported by staining with the polyclonal OC antibody recognizing fibrillar Ab oligomers and Ab fibrils [32] . An intense intraneuronal Ab staining was observed after heat pretreatment as well as with additional FA pretreatment that enhanced intraneuronal OC staining. This is in contrast to the deleterious effects of FA pretreatment on the detection of Ab 1-x , but agrees with the suggestion that FA enhances the staining of aggregated Ab fibrils recognized by the OC antibody. The staining retrieved by heat pretreatment could thus be due to detection of oligomeric Fig. 4 Rating of intraneuronal Ab 1-x staining intensity. ??? was assigned to cases with very strong intraneuronal Ab staining in CA4, CA3, as well as in CA1 (a-c). ?? was assigned to cases with weaker but still obvious intracellular Ab staining in CA4 and CA3 and low staining in CA1 (d-f). ? was assigned to cases with a very faint intracellular Ab staining in CA4 and CA3 and apparently no staining in CA1 (g-i). 0 was assigned to cases showing no intracellular Ab staining either in CA4, CA3, or CA1 (j-l).
Scale bar 50 lm
Ab fibrils by the OC antibody, which is consistent with two previous studies suggesting that Ab oligomerization starts within neurons [59, 64] .
It is known that besides Ab peptides starting with an aspartate at position 1, a variety of different N-terminal truncated Ab peptides have been identified in AD brain tissue [28, 53] . Especially compact Ab deposits in human brain often contain pronounced N-terminal degradation and post-translational modifications [36] . While N-terminal modifications of Ab have been identified to occur within neurons [8] , it is likely that the majority of intraneuronal Ab peptides start with the aspartic acid at position 1 as cleavage by BACE is the initial step for Ab generation.
Intraneuronal Ab originates exclusively from intraneuronal sources. Whether it can, in addition, be internalized from external sources is not yet clarified. Yet, much evidence supports the possibility of a reuptake of Ab peptides into cells by endocytosis, and members of the lipoprotein receptor (LDLR) family [9] , a7 nicotinic receptors [46] , as well as scavenger receptor for advanced glycation end products (RAGE) [21, 56, 71] have all been reported to interact with Ab and to be capable of internalization of extracellular Ab peptides. In particular, RAGE-Ab complexes have been shown to be internalized and co-localize with the lysosomal pathway in astrocytes in AD brains [56] . This is supported by our observation of astrocytes accumulating high amounts of Ab granules.
The LDLR-related protein (LRP) is a member of the LDLR family and functions as an ApoE receptor. LRP has been shown to facilitate rapid endocytosis of APP promoting APP processing and thus Ab generation. In addition to the effect on APP trafficking, LRP-induced rapid endocytosis also facilitates cellular uptake of Ab peptides from the extracellular space, either directly through binding to Ab or indirectly through interaction with ligands such as ApoE [9] . Accordingly, knock out of APOE in PDAPP transgenic mice reduced the accumulation of intracellular Ab [72] . Given this possible role for ApoE in the intraneuronal Ab accumulation, we correlated the intensity of the intraneuronal Ab 1-x staining in the hippocampal regions of 20 AD patients and 10 controls to ApoE genotype and found a highly significant correlation between having one ApoE4 allele and the intensity of Ab 1-x staining (P = 0.002). This is an interesting finding as ApoE4 plays an important role in neurodegeneration in general and in AD in particular (reviewed in [43] ). The e4 allele of the ApoE gene is the major known genetic risk factor for AD with a frequency of *15% in general populations but [50% in AD patients [16] . Moreover, ApoE4 influences beta-amyloid degradation [73] brain and neuronal activity [39, 55] while senile plaques are more frequent in ApoE4-carriers compared to non-carriers. This was most evident during the age of 50-59 years, with *41% of e4-carriers bearing senile plaques, compared to only *8% in non-carriers [34] . This suggests that there is a differential development of AD-associated changes in the brain of individuals having at least one e4 allele, which starts already in middle age.
Crossing PDAPP mice with mice in which the endogenous mouse ApoE was substituted with human ApoE2, ApoE3 or ApoE4 resulted in a substantial and early increase in brain Ab42 levels, prior to extracellular plaque deposition [5] . In addition, intraneuronal Ab accumulation has been previously linked to ApoE. PDAPP mice overexpressing mLRP2 had higher hippocampal detergentsoluble Ab42 levels than PDAPP wildtype mice. Furthermore, cortical intraneuronal Ab42 was significantly reduced in PDAPP mice lacking ApoE, leading to the assumption that ApoE facilitates intraneuronal Ab accumulation [72] . ApoE4-transgenic mice housed in an enriched environment showed increased levels of oligomerization and deposition of Ab peptides in hippocampal neurons compared to ApoE3-transgenic mice housed under the same conditions [38] . Furthermore, inhibition of the Ab-degrading enzyme neprilysin in ApoE3 and ApoE4 mice results in an ApoE4 isoform-specific degeneration of hippocampal CA1 neurons, which is accompanied by intracellular accumulation of Ab and ApoE and lysosomal activation [6] . In good agreement with this lysosomal pathology, altered endocytic pathway activity is one of the earliest known intraneuronal changes occurring in sporadic AD, and it has been shown that the ApoE4 genotype promotes early-stage endocytic pathway activation [11] . In conclusion, having optimized techniques for reliable detection of intraneuronal Ab, our subsequent analysis revealed a strong association between the ApoE4 genotype and the presence of intraneuronal Ab. These results confirm recent data obtained in experimental settings and are consistent with an important role for intracellular Ab metabolism, possibly mediated through ApoE4, in AD etiology.
